Hiroaki Nonaka

1.3k total citations · 1 hit paper
30 papers, 880 citations indexed

About

Hiroaki Nonaka is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Hiroaki Nonaka has authored 30 papers receiving a total of 880 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 7 papers in Molecular Biology and 7 papers in Genetics. Recurrent topics in Hiroaki Nonaka's work include Acute Myeloid Leukemia Research (11 papers), Acute Lymphoblastic Leukemia research (4 papers) and Hemoglobinopathies and Related Disorders (4 papers). Hiroaki Nonaka is often cited by papers focused on Acute Myeloid Leukemia Research (11 papers), Acute Lymphoblastic Leukemia research (4 papers) and Hemoglobinopathies and Related Disorders (4 papers). Hiroaki Nonaka collaborates with scholars based in Japan and United States. Hiroaki Nonaka's co-authors include Masao Tomonaga, Dale L. Preston, Atsushi Kuramoto, Shizue Izumi, Desmond Thompson, Kiyóhiko Mabuchi, Shizuyo Kusumi, Nanao Kamada, Midori Soda and Elaine Ron and has published in prestigious journals such as Blood, British Journal of Haematology and Radiation Research.

In The Last Decade

Hiroaki Nonaka

26 papers receiving 809 citations

Hit Papers

Cancer Incidence in Atomic Bomb Survivors. Part III: Leuk... 1994 2026 2004 2015 1994 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroaki Nonaka Japan 9 309 220 168 140 138 30 880
Shizuyo Kusumi Japan 8 428 1.4× 120 0.5× 112 0.7× 81 0.6× 154 1.1× 14 774
J D Boice United States 10 376 1.2× 30 0.1× 110 0.7× 227 1.6× 185 1.3× 10 1.1k
Wayne H. Borges United States 11 108 0.3× 134 0.6× 150 0.9× 65 0.5× 156 1.1× 15 662
Jean-Michel Lutz Switzerland 7 49 0.2× 260 1.2× 162 1.0× 299 2.1× 63 0.5× 9 856
M. Beauduin Belgium 18 160 0.5× 142 0.6× 211 1.3× 662 4.7× 330 2.4× 70 1.2k
Jukka Rajantie Finland 27 86 0.3× 670 3.0× 350 2.1× 96 0.7× 537 3.9× 83 2.0k
David Pfister Germany 22 249 0.8× 69 0.3× 369 2.2× 246 1.8× 1.2k 8.5× 200 2.2k
Jon B. Reitan Norway 20 407 1.3× 25 0.1× 127 0.8× 209 1.5× 383 2.8× 47 1.1k
J. Hense Germany 15 79 0.3× 65 0.3× 74 0.4× 231 1.6× 122 0.9× 56 589
Fotini Tzortzatou Greece 10 63 0.2× 35 0.2× 86 0.5× 138 1.0× 37 0.3× 24 577

Countries citing papers authored by Hiroaki Nonaka

Since Specialization
Citations

This map shows the geographic impact of Hiroaki Nonaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Nonaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Nonaka more than expected).

Fields of papers citing papers by Hiroaki Nonaka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Nonaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Nonaka. The network helps show where Hiroaki Nonaka may publish in the future.

Co-authorship network of co-authors of Hiroaki Nonaka

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Nonaka. A scholar is included among the top collaborators of Hiroaki Nonaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Nonaka. Hiroaki Nonaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hirai, Keiji, Hiroaki Nonaka, Shohei Kaneko, et al.. (2022). Effects of Elobixibat on Constipation and Lipid Metabolism in Patients With Moderate to End-Stage Chronic Kidney Disease. Frontiers in Medicine. 8. 780127–780127.
3.
Hirai, Keiji, Hiroaki Nonaka, Shohei Kaneko, et al.. (2021). Effects of Roxadustat on the Anemia and Iron Metabolism of Patients Undergoing Peritoneal Dialysis. Frontiers in Medicine. 8. 667117–667117. 16 indexed citations
5.
Taneichi, Akiyo, Hiroyuki Fujiwara, Shizuo Machida, et al.. (2014). Disseminated Intravascular Coagulopathy Caused by Uterine Leiomyoma with Sarcoma-Like Findings on Magnetic Resonance Imaging. Case Reports in Obstetrics and Gynecology. 2014. 1–4. 2 indexed citations
6.
Matsubara, Shigeki, Akihide Ohkuchi, Hiroaki Nonaka, Homare Ito, & Alan Kawarai Lefor. (2014). Prolapse of the Small Intestine from the Uterine Perforation at Dilatation and Curettage. Case Reports in Obstetrics and Gynecology. 2014. 1–4. 4 indexed citations
7.
Matsubara, Shigeki, Hiroaki Nonaka, Mami Kobayashi, Akira Kawai, & Hiroyuki Fujii. (2014). Uterine artery pseudoaneurysm after dilation and curettage in a woman with multiple hepatic and pulmonary cavernous hemangiomas. International Journal of Gynecology & Obstetrics. 125(1). 84–85. 7 indexed citations
9.
Sato, Naoto, Yasushi Saga, Hiroaki Mizukami, et al.. (2012). Downregulation of indoleamine-2,3-dioxygenase in cervical cancer cells suppresses tumor growth by promoting natural killer cell accumulation. Oncology Reports. 28(5). 1574–1578. 35 indexed citations
10.
Wang, Dongdong, Yasushi Saga, Hiroaki Mizukami, et al.. (2011). Indoleamine-2,3-dioxygenase, an immunosuppressive enzyme that inhibits natural killer cell function, as a useful target for ovarian cancer therapy. International Journal of Oncology. 40(4). 929–934. 64 indexed citations
11.
Yoshida, Shinichiro, Kazutaka Kuriyama, Yasushi Miyazaki, et al.. (2001). De novo acute myeloid leukemia in the elderly; a consistent fraction of long-term survivors by standard-dose chemotherapy. Leukemia Research. 25(1). 33–38. 9 indexed citations
12.
Nakamura, H., Naoki Sadamori, M. Mine, et al.. (1992). Effects of short-term liquid cultures of peripheral blood mononuclear cells with recombinant human granulocyte or granulocyte-macrophage colony-stimulating factor in cytogenetic studies of myelofibrosis with myeloid metaplasia.. PubMed. 6(8). 853–5. 2 indexed citations
13.
Moriuchi, Yukiyoshi, Mitsuhiro Yamamura, Hirotada Mori, et al.. (1990). [Comparison of ciprofloxacin with polymyxin B for infection prophylaxis in neutropenic patients with acute non-lymphocytic leukemia].. PubMed. 31(10). 1664–9. 7 indexed citations
14.
Tomonaga, Masao, Itsuro Jinnai, Hiroaki Nonaka, et al.. (1989). [Study on pathophysiology of the myelodysplastic syndromes (MDS)--pattern of dysmegakaryopoiesis related to leukemic transformation].. PubMed. 30(10). 1788–99. 1 indexed citations
15.
Jinnai, Itsuro, Masao Tomonaga, Kazutaka Kuriyama, et al.. (1987). Dysmegakaryocytopoiesis in acute leukaemias: its predominance in myelomonocytic (M4) leukaemia and implication for poor response to chemotherapy. British Journal of Haematology. 66(4). 467–472. 39 indexed citations
17.
Matsuo, Tatsuki, Masao Tomonaga, Kazutaka Kuriyama, et al.. (1986). Prognostic significance of the morphological dysplastic changes in chronic myelogenous leukemia. Leukemia Research. 10(3). 331–337. 8 indexed citations
18.
Kuriyama, Kazutaka, Masao Tomonaga, Hiroaki Nonaka, et al.. (1986). Dual expression of lymphoid/basophil markers on single blast cells transformed from chronic myeloid leukemia. Leukemia Research. 10(8). 1015–1024. 1 indexed citations
19.
Kuriyama, Kazutaka, Masao Tomonaga, Hiroaki Nonaka, et al.. (1985). A comparative study of immunological and cytochemical profiles between adult and childhood acute lymphoblastic leukemias (ALLs): Heterogeneity in adult common ALL. Leukemia Research. 9(10). 1237–1247. 4 indexed citations
20.
Matsuo, Tatsuki, Masao Tomonaga, Kazutaka Kuriyama, et al.. (1985). CFU-C abnormalities and cytochemical defects in bone marrow of adult patients during remission of acute leukemia. Leukemia Research. 9(5). 613–616. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026